Humana Inc (HUM)
Humana Inc (HUM) carries a ŷRobot AI score of 61 out of 100. The model's fair value estimate is $433.09, 4.7% above the last close of $413.61. The chart signal reads Sell.
| Metric | HUM |
|---|---|
| AI score | 61 / 100 |
| Chart signal | Sell |
| Fair value estimate | $433.09 |
| Upside to fair value | 4.7% |
| Previous close | $413.61 |
| P/E | 36.10 |
| Price / sales | 0.31 |
| Market cap | $51.32B |
| EPS | 10.57 |
| Revenue growth | 10.9% |
| 1-year price change | -2.8% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about HUM
Is HUM overvalued or undervalued right now?
As of Oct 16, 2026, ŷRobot's fair-value model estimates Humana Inc (HUM) at $433.09 against a last close of $413.61, implying 4.7% upside to the model's estimate.
Is HUM's chart signal bullish or bearish?
The chart-signal model classifies HUM as Neutral as of Oct 16, 2026, with a signal score of -0.13 on a -1 to 1 scale.
What is HUM's ŷRobot AI score?
HUM scores 61 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 16, 2026.
Is HUM stock expensive on P/E and P/S?
HUM trades at 36.1 times earnings and 0.3 times sales as of Oct 16, 2026.
What does HUM's seasonal forecast show?
ŷRobot's seasonal forecast curve for HUM reads +2.2% at 30 days, -1.6% at 90 days, and -2.8% at one year as of Oct 16, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is HUM growing?
Humana Inc's revenue growth is +10.9% and free-cash-flow growth is +63.7% on the latest reported figures.
HUM chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.